WuXi AppTec Becomes Third-Largest Active Fund Holding as Public Funds Raise Stakes

The signal here is positioning, not fundamentals: a contract research and manufacturing name climbing to the top tier of active fund holdings shows where domestic institutional conviction has migrated within the innovative drug supply chain. That concentration cuts both ways — crowded ownership can amplify moves in either direction once sentiment shifts. The open question is whether the sentiment improvement institutions expect is matched by order flow and earnings visibility, or remains a fund-flow story.